102 related articles for article (PubMed ID: 20463644)
1. Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials.
Barraclough KA; Isbel NM; Staatz CE
Transplantation; 2010 Jul; 90(1):44-51. PubMed ID: 20463644
[TBL] [Abstract][Full Text] [Related]
2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
3. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
[TBL] [Abstract][Full Text] [Related]
4. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
Barraclough KA; Isbel NM; Franklin ME; Lee KJ; Taylor PJ; Campbell SB; Petchey WG; Staatz CE
Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.
Hulin A; Blanchet B; Audard V; Barau C; Furlan V; Durrbach A; Taïeb F; Lang P; Grimbert P; Tod M
Ther Drug Monit; 2009 Apr; 31(2):224-32. PubMed ID: 19214145
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.
Barraclough KA; Isbel NM; Kirkpatrick CM; Lee KJ; Taylor PJ; Johnson DW; Campbell SB; Leary DR; Staatz CE
Br J Clin Pharmacol; 2011 Feb; 71(2):207-23. PubMed ID: 21219401
[TBL] [Abstract][Full Text] [Related]
8. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
10. Performance of limited sampling strategies for predicting mycophenolic acid area under the curve in thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Ignaszewski AP; Ensom MH
J Heart Lung Transplant; 2008 Mar; 27(3):325-8. PubMed ID: 18342756
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of mycophenolic acid in renal transplant recipients.
Okamoto M; Wakabayashi Y; Higuchi A; Kadotani Y; Ogino S; Ushigome H; Akioka K; Kaihara S; Yoshimura N
Transplant Proc; 2005 Mar; 37(2):859-60. PubMed ID: 15848556
[TBL] [Abstract][Full Text] [Related]
12. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?
de Winter BC; Mathôt RA; van Hest RM; van Gelder T
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):251-61. PubMed ID: 17428154
[TBL] [Abstract][Full Text] [Related]
17. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
[TBL] [Abstract][Full Text] [Related]
18. Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoring.
Ray JE; Keogh AM; McLachlan AJ
J Heart Lung Transplant; 2006 Oct; 25(10):1223-9. PubMed ID: 17045935
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of limited sampling strategies for tacrolimus.
Op den Buijsch RA; van de Plas A; Stolk LM; Christiaans MH; van Hooff JP; Undre NA; van Dieijen-Visser MP; Bekers O
Eur J Clin Pharmacol; 2007 Nov; 63(11):1039-44. PubMed ID: 17712551
[TBL] [Abstract][Full Text] [Related]
20. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Ostrowska J; Gralak B; Majchrzak J
Transplant Proc; 2006; 38(1):86-9. PubMed ID: 16504671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
